Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Other Non-Current Assets (2016 - 2026)

Balchem (BCPC) has disclosed Other Non-Current Assets for 17 consecutive years, with $18.7 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 8.42% year-over-year to $18.7 million; the TTM value through Mar 2026 reached $18.7 million, up 8.42%, while the annual FY2025 figure was $18.1 million, 4.72% up from the prior year.
  • Other Non-Current Assets hit $18.7 million in Q1 2026 for Balchem, up from $18.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $18.7 million in Q1 2026 and bottomed at $13.5 million in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $16.6 million, with a median of $17.2 million recorded in 2024.
  • Year-over-year, Other Non-Current Assets rose 29.5% in 2022 and then rose 0.11% in 2025.
  • Balchem's Other Non-Current Assets stood at $15.1 million in 2022, then rose by 12.1% to $16.9 million in 2023, then rose by 2.18% to $17.3 million in 2024, then grew by 4.72% to $18.1 million in 2025, then increased by 3.05% to $18.7 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $18.7 million, $18.1 million, and $18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.